Latest News

Publications

October 6, 2021

A selective antibiotic for Lyme disease

Nadja Leimer, Xiaoqian Wu, Yu Imai, Linden T. Hu, Helen I. Zgurskaya, Kim Lewis

October 1, 2020

A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients

Madeleine Morrissette, Norman Pitt, Antonio González, Philip Strandwitz, Mariaelena Caboni, Alison W. Rebman, Rob Knight, Anthony D’Onofrio, John N. Aucott, Mark J. Soloski, Kim Lewis

March 2, 2020

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31

Venkata Raveendra Pothineni, Hari-Hara S. K. Potula, Aditya Ambati, Venkata Vamsee Aditya Mallajosyula, Brindha Sridharan, Mohammed Inayathullah, Mohamed Sohail Ahmed, and Jayakumar Rajadas

December 16, 2019

Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group

By Samuel Shor, Christine Green, Beatrice Szantyr, Steven Philips, Kenneth Liegner, Joseph Burrascano Jr., Robert Bransfield, Elizabeth L. Maloney

November 16, 2009

Ineffectiveness of tigecycline against persistent Borrelia burgdorferi

By Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ

02-01-2023

Neuro Symptoms/CU Research Proposals/LD Lang.Deficits/Portals Billed/Ticks:Burns/Tick Genome/Research Award/Powassan/BB Barrier/Relapsing fever:AL/Inflamm. Mediators/Herx & Babesia/Transfusion/BourbonV

01-30-2023

Update on Tickborne Bourbon Virus in the US

01-30-2023

Transfusion-Transmitted Babesiosis Via Red Cell Exchange in Sickle Cell Disease Patient

01-29-2023

Alessandra Luchini Recognized With 2023 Outstanding Faculty Award

01-27-2023

Jarisch-Herxheimer Reaction and Babesia Complicate Lyme Case

01-27-2023

Powassan Virus Detected in D. Variabilis Ticks in New York